chronic atrophic gastritis
Conditions
Interventions
3-month treatment of Weierkang:oral administration for 3 months
6-month treatment of Weierkang:oral administration for 6 months
Sponsors
Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University
Eligibility
Sex/Gender
All
Age
25 Years to 78 Years
Inclusion criteria
Inclusion criteria: Referring to consensus on chronic gastritis in China(Shanghai, 2012), diagnostic criteria are listed as follows: Inclusion criteria 1. Outpatients of CAG from March,2014 to March,2015 at Sir Run Run Shaw Hospital; 2. Aged between 20 and 70 years old.
Exclusion criteria
Exclusion criteria: Exclusion criteria 1. Combined with malignant tumor,espencially esophageal cancer and gastric cancer; ulcer, barretts esophagus or other upper GI diseases; 2. Acid inhibitors (H2 antagonists or proton pump inhibitors)promote power medicine (mosapride or domperidone, etc.) or gastric mucosa protectant for pury (teprenone, sucralfate, gefarnate, glutamine, rebamipide, bismuth, etc.) were taken two weeks before this trial; 3. Serious comorbidities of heart, lung, liver, kidney or blood system; 4. Female patients preparing for a baby, pregnant or lactating; 5. Dropping out of this trials before the end of treatment, or can't cooperate with researchers.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Total effective rate ; | — |
Countries
China
Contacts
Public ContactWang Kan
Sir Run Run Shaw Hospital, College of Medicine, Zhejiang University
Outcome results
None listed